The trajectory of the erectile dysfunction drug presents a intricate picture for investors. While the initial release generated substantial gains, the expiration of its patent opened the avenue to generic alternatives, https://peakbookmarks.com/story21720653/viagra-and-the-pharmaceutical-industry-a-risky-bet